215 related articles for article (PubMed ID: 19067412)
1. Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
Moran G; Dillon J; Green J
Inflamm Bowel Dis; 2009 Sep; 15(9):1281-2. PubMed ID: 19067412
[No Abstract] [Full Text] [Related]
2. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
[No Abstract] [Full Text] [Related]
3. Pancytopenia in a Young Male Patient With Inflammatory Bowel Disease.
Jansson-Knodell CL; Walker MJ; Fischer M
Gastroenterology; 2021 Apr; 160(5):1483-1485. PubMed ID: 32777287
[No Abstract] [Full Text] [Related]
4. Hepatosplenic αβ T-cell lymphoma associated with azathioprine therapy.
Rashidi A; Lee ME; Fisher SI
Int J Hematol; 2012 May; 95(5):592-4. PubMed ID: 22527855
[No Abstract] [Full Text] [Related]
5. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
[TBL] [Abstract][Full Text] [Related]
6. Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis.
Brinkert F; Arrenberg P; Krech T; Grabhorn E; Lohse A; Schramm C
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27516526
[TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.
Zeidan A; Sham R; Shapiro J; Baratta A; Kouides P
Leuk Lymphoma; 2007 Jul; 48(7):1410-3. PubMed ID: 17613771
[No Abstract] [Full Text] [Related]
8. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
Ochenrider MG; Patterson DJ; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
[TBL] [Abstract][Full Text] [Related]
9. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
Drini M; Prichard PJ; Brown GJ; Macrae FA
Med J Aust; 2008 Oct; 189(8):464-5. PubMed ID: 18928444
[TBL] [Abstract][Full Text] [Related]
10. Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J
Intern Med J; 2014 Mar; 44(3):287-90. PubMed ID: 24621284
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.
Parakkal D; Sifuentes H; Semer R; Ehrenpreis ED
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1150-6. PubMed ID: 21941193
[TBL] [Abstract][Full Text] [Related]
12. [Immunodepressants in the treatment of Crohn's disease and non-specific ulcerative colitis].
Radbil' OS
Klin Med (Mosk); 1976 Mar; 54(3):8-14. PubMed ID: 787661
[No Abstract] [Full Text] [Related]
13. [Azathioprine in chronic inflammatory bowel diseases. Evidence base].
Herrlinger K; Stange EF
Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301
[TBL] [Abstract][Full Text] [Related]
14. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?
Rosh JR; Gross T; Mamula P; Griffiths A; Hyams J
Inflamm Bowel Dis; 2007 Aug; 13(8):1024-30. PubMed ID: 17480018
[TBL] [Abstract][Full Text] [Related]
15. Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.
Selvaraj SA; Chairez E; Wilson LM; Lazarev M; Bass EB; Hutfless S
Syst Rev; 2013 Jul; 2():53. PubMed ID: 23826928
[TBL] [Abstract][Full Text] [Related]
16. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
[TBL] [Abstract][Full Text] [Related]
17. The drug therapy of ulcerative colitis and of Crohn's disease.
Tumen HJ
Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
[No Abstract] [Full Text] [Related]
18. Development of Leiomyosarcoma in a Patient Treated with Azathioprine.
Abdallah M; Saleh M; Elgouhari H; Huntington MK
S D Med; 2019 May; 72(5):214-216. PubMed ID: 31454474
[TBL] [Abstract][Full Text] [Related]
19. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
20. [Conservative therapy of ulcerative colitis--long-term experience].
Kölbel C; Goebell H
Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
[No Abstract] [Full Text] [Related]
[Next] [New Search]